[Inhibition of prostaglandin synthesis suppresses the renal functional reserve in patients with lupus nephropathy].
Herrera-Acosta
J
J
Reyes
P A
PA
López Manay
G
G
Padilla
L
L
Cerdas Calderón
M
M
Ruiz
A
A
Pérez Grovas
H
H
D000328:Adult; D015232:Dinoprostone; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D008181:Lupus Nephritis / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D011448:Prostaglandin Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D011458:Prostaglandins E / Q000652:urine*; D012083:Renin / Q000097:blood*
D011448:Prostaglandin Antagonists; D011458:Prostaglandins E; D012083:Renin; D015232:Dinoprostone; D007213:Indomethacin
La inhibición de la síntesis de prostaglandinas suprime la reserva funcional renal en pacientes con nefropatía lúpica.